DNA Synthesis Market Outlook:
DNA Synthesis Market size was over USD 5.32 billion in 2025 and is projected to reach USD 27.61 billion by 2035, growing at around 17.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of DNA synthesis is assessed at USD 6.18 billion.
DNA synthesis plays a vital role in the production of personalized medicine, particularly in gene therapy and oncology. Customized or personalized medications are formulated considering factors such as lifestyle and genetic makeup. In most chronic disorder cases such as cancer, the one-fits-all treatment approach does not work and increases the demand for personalized medicines. Researchers through DNA sequencing of tumor cells identify mutations or alterations that lead to cancer progression and further through DNA synthesis they create specific gene constructs or proteins that target the mutations directly, reduce their growth, and offer better treatment results. The increasing cases of chronic disorders such as cancer are augmenting the high demand for synthetic DNA solutions.
Key players in the DNA synthesis market are raising funds to enhance their research capabilities and aid researchers to drive their full potential to develop advanced solutions. For instance, in April 2023, ANSA Biotechnologies revealed that the company raised USD 68 million in Series A Funding to enhance DNA synthesis. This funding is aiding the company in advancing next-gen technology platforms, expanding production and R&D facilities, increasing multidisciplinary teams, and introducing DNA synthesis services.
